Sara Van Kalker
About Sara Van Kalker
Sara Van Kalker is a Clinical Account Specialist with a diverse background in engineering and entrepreneurship, currently working at Biosense Webster in Seattle, Washington. She has previously held roles at various institutions, including Texas A&M University and Georgia Institute of Technology, and possesses expertise in medical device commercialization and regulatory processes.
Current Role at Biosense Webster
Sara Van Kalker has been serving as a Clinical Account Specialist at Biosense Webster since 2021. In this role, she is responsible for managing clinical accounts and providing support for medical devices. Her position is based in Seattle, Washington, where she applies her expertise in regulatory and reimbursement processes for medical devices.
Previous Experience at Biosense Webster
Prior to her current role, Sara worked as an Associate Clinical Account Specialist at Biosense Webster from 2020 to 2021. During this time, she gained valuable experience in clinical account management and contributed to the company's operations in Seattle, Washington.
Education and Expertise
Sara Van Kalker holds a Master's degree in Biomedical Innovation and Development from Georgia Institute of Technology, which she completed from 2019 to 2020. She also earned a Bachelor's degree in Mechanical Engineering from Texas A&M University, where she studied from 2014 to 2018. Her educational background is complemented by her expertise in regulatory and reimbursement processes for medical devices.
Background in Engineering and Entrepreneurship
Sara has a diverse background that combines engineering and entrepreneurship. She co-founded CTRL and served as Chief Product Officer from 2017 to 2019. This experience, along with her work in various research and engineering roles, has equipped her with skills in interdisciplinary team communication and critical thinking, which she applies in the medical technology field.
Research and Market Analysis Experience
Sara's experience includes working as a Market Analyst at Biolocity for six months in 2020, where she focused on the commercialization of medical devices. Additionally, she held research positions at Texas A&M University, including a role in the Biorobotics Lab from 2018 to 2019 and as a Student Researcher in 2017.